Overview
Developing high-performance industrial enzymes, specialty enzymes, and pharmaceutical and health ingredients through AI enzyme design and directed evolution
Funding
USD estimates from the source recordListed 1 funding record. Latest funding: $714K (种子轮), May 13, 2025.
| Date | Amount | Investors | Source |
|---|---|---|---|
| May 13, 2025 | $714K | Yizhan Capital |
Valuation
USD estimates from the source recordListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| May 13, 2025 | — | Yizhan Capital |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
结合AI酶设计与定向进化开发高性能工业酶、特种酶和医药健康原料